Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), net
Class A Common Stock
Common Stock
Class A Common Stock
Treasury Stock
Class B Common Stock
Common Stock
Class B Common Stock
Treasury Stock
Beginning balance (in shares) at Sep. 30, 2022         41,195,730   14,275,867  
Beginning balance at Sep. 30, 2022 $ 455,879 $ 256,571 $ 197,274 $ 17,620 $ 41 $ (39) $ 15 $ (15,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 1,892   1,892          
Share-based compensation expense 2,480 2,480            
Issuance of stock awards (in shares)         180,798      
Purchase of treasury stock (139)         (139)    
Other comprehensive income (loss) (1,256)     (1,256)        
Ending balance (in shares) at Dec. 31, 2022         41,376,528   14,275,867  
Ending balance at Dec. 31, 2022 458,856 259,051 199,166 16,364 $ 41 (178) $ 15 (15,603)
Beginning balance (in shares) at Sep. 30, 2022         41,195,730   14,275,867  
Beginning balance at Sep. 30, 2022 455,879 256,571 197,274 17,620 $ 41 (39) $ 15 (15,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (3,589)              
Other comprehensive income (loss) (4,635)              
Ending balance (in shares) at Mar. 31, 2023         41,376,528   14,275,867  
Ending balance at Mar. 31, 2023 452,688 261,743 193,685 12,985 $ 41 (178) $ 15 (15,603)
Beginning balance (in shares) at Dec. 31, 2022         41,376,528   14,275,867  
Beginning balance at Dec. 31, 2022 458,856 259,051 199,166 16,364 $ 41 (178) $ 15 (15,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (5,481)   (5,481)          
Share-based compensation expense 2,692 2,692            
Other comprehensive income (loss) (3,379)     (3,379)        
Ending balance (in shares) at Mar. 31, 2023         41,376,528   14,275,867  
Ending balance at Mar. 31, 2023 452,688 261,743 193,685 12,985 $ 41 (178) $ 15 (15,603)
Beginning balance (in shares) at Sep. 30, 2023         43,760,546   11,921,463  
Beginning balance at Sep. 30, 2023 516,574 267,330 246,275 18,694 $ 44 (178) $ 12 (15,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 9,843   9,843          
Share-based compensation expense 2,783 2,783            
Issuance of stock awards (in shares)         135,471      
Purchase of treasury stock (1,336)         (1,336)    
Other comprehensive income (loss) (6,705)     (6,705)        
Ending balance (in shares) at Dec. 31, 2023         43,896,017   11,921,463  
Ending balance at Dec. 31, 2023 521,159 270,113 256,118 11,989 $ 44 (1,514) $ 12 (15,603)
Beginning balance (in shares) at Sep. 30, 2023         43,760,546   11,921,463  
Beginning balance at Sep. 30, 2023 516,574 267,330 246,275 18,694 $ 44 (178) $ 12 (15,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 8,719              
Other comprehensive income (loss) (4,313)              
Ending balance (in shares) at Mar. 31, 2024         43,896,017   11,921,463  
Ending balance at Mar. 31, 2024 524,983 272,669 254,994 14,381 $ 44 (1,514) $ 12 (15,603)
Beginning balance (in shares) at Dec. 31, 2023         43,896,017   11,921,463  
Beginning balance at Dec. 31, 2023 521,159 270,113 256,118 11,989 $ 44 (1,514) $ 12 (15,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (1,124)   (1,124)          
Share-based compensation expense 2,556 2,556            
Other comprehensive income (loss) 2,392     2,392        
Ending balance (in shares) at Mar. 31, 2024         43,896,017   11,921,463  
Ending balance at Mar. 31, 2024 $ 524,983 $ 272,669 $ 254,994 $ 14,381 $ 44 $ (1,514) $ 12 $ (15,603)